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Natriuretic peptide receptor A (NPR-A) is an essential car-
diovascular regulator that is stimulated by atrial natriu-
retic peptide and brain natriuretic peptide, whereas
natriuretic peptide receptor B (NPR-B) stimulates long
bone growth in a C-type natriuretic peptide-dependent
manner. Many reports indicate that ATP is essential for
NPR-A and NPR-B activation. Current models suggest that
natriuretic peptide binding to receptor extracellular
domains causes ATP binding to intracellular kinase
homology domains, which derepresses adjacent catalytic
domains. Here, we report 100-fold activation of natriu-
retic peptide receptors in the absence of ATP. Addition of
a nonhydrolyzable ATP analog had no effect at early time
periods (seconds) but increased cGMP production about
two-fold after longer incubations (minutes), consistent
with a stabilization, not activation, mechanism. These
data indicate that ATP does not activate natriuretic pep-
tide receptors. Instead, ATP increases activity primarily by
maintaining proper receptor phosphorylation status, but
also serves a previously unappreciated enzyme stabilizing
function.
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